The effect of tuberculosis and antiretroviral treatment on CD4+ cell count response in HIV-positive tuberculosis patients in Mozambique
- PMID: 22900904
- PMCID: PMC3490938
- DOI: 10.1186/1471-2458-12-670
The effect of tuberculosis and antiretroviral treatment on CD4+ cell count response in HIV-positive tuberculosis patients in Mozambique
Abstract
Background: Tuberculosis (TB) presents a serious problem in Mozambique. HIV prevalence among TB patients is estimated at 47%. A delay in having their first CD4+ cell count could lead to a missed opportunity for ART initiation due to a CD4+ cell increase above the cut-off caused by TB treatment. The objective is to describe CD4+ cell response during TB treatment and quantify the effect of TB treatment and ART on this response.
Methods: All new HIV + adult TB cases in 2007 from three TB clinics in Mozambique were included. Data on TB diagnosis and treatment and HIV parameters were collected. A general mixed model was used for CD4+ cell count response.
Results: 338 HIV + patients were notified and 252 (75%) were included in the analysis. Using TB medication was not independently associated with the CD4+ count response (19 cells/mm3; 95% CI: -40 to 79; p = 0.529). ART-use was associated with statistically significantly higher CD4+ cells compared to no ART-use (81 cells/mm3; 95% confidence interval (CI): 12 to 151; p = 0.022).
Conclusion: In this study, no independent effect of TB treatment on CD4+ cell count was found. HIV-infected TB patients on ART had a significantly higher CD4+ cell count than those not receiving ART. CD4+ cell counts for patients not on ART at TB treatment start, remained below the cut off for initiating ART during the first three months of TB treatment; therefore some delay in getting the first CD4+ cell count would not lead to missing the opportunity to start ART.
Figures
References
-
- World Health Organization Report 2009 Global Tuberculosis Control. Surveillance, Planning, Financing. WHO/HTM/TB; 2009. p. 411.
-
- Mac-Arthur A Jr, Gloyd S, Perdigão P, Noya A, Sacarlal J, Kreiss J. Characteristics of drug resistance and HIV among tuberculosis patients in Mozambique. Int J Tuberc Lung Dis. 2009;5(10):894–902. - PubMed
-
- Ministério de Saúde da República de Moçambique. Departemento Nacional da Assistência Médica. Programa Nacional de Controle das ITS/HIV/SIDA. Ronda de Vigilância epidemiológica do HIV de. 2007.
-
- Chimzizi R, Gausi F, Bwanali A, Mbalume D, Teck R, Gomani P, Zachariah R, Zuza W, Malombe R, Salaniponi FM, Harries AD. Voluntary counselling, HIV testing and adjunctive cotrimoxazole are associated with improved TB treatment outcomes under routine conditions in Thyolo District, Malawi. Int J Tuberc Lung Dis. 2004;8(5):579–585. - PubMed
-
- Mwinga A, Mwananyambe N, Kanene C, Bulterys M, Phiri C, Kapata N, Mukonka V, Nadol P, Patel M, Nakashima A. Provider-initiated HIV testing and counseling of TB patients - Livingstone District, Zambia, September 2004-December 2006. MMWR Morb Mortal Wkly Rep. 2008;57(11):285–289. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials